ReviewCurrent opinion in ophthalmology2013
Update on depression and age-related macular degeneration.
Review in Current opinion in ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 106 citations in OpenAlex.
- Pooled it
- Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis.JAMA ophthalmology · 2021Pooled it
- Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.BMC psychiatry · 2017Trial
- Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration.Investigative ophthalmology & visual science · 2017Trial
- Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial.BMJ (Clinical research ed.) · 2015Trial
- Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.Ophthalmology · 2014Trial
- Article
- Non neovascular Age - related macular degeneration - Review on clinical and imaging advances.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Review
- Cell therapy for age-related macular degeneration.Mammalian genome : official journal of the International Mammalian Genome Society · 2026Review
- Risk of Depression, Anxiety, and Suicidal Behavior in Older Adults With Severe Vision Loss.Journal of vitreoretinal diseases · 2026Article
- [Mental comorbidities among patients receiving intravitreal operative drug injections].Die Ophthalmologie · 2026Article
- Pre- and post-operative evaluation of psychological well-being and vision-specific quality of life in cataract patients.International ophthalmology · 2026Observational
- Swept-Source Optical Coherence Tomography Angiography for Retinal Neurovascular Structural Evaluation in a Chronic Unpredictable Mild Stress Rat Model.Translational vision science & technology · 2025Article
- Association of visual and hearing impairments with all-cause mortality in older adults in China.BMC geriatrics · 2025Article
- Diagnostic testing in the genetically complex age-related macular degeneration.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2025Article
- Nonarteritic anterior ischemic optic neuropathy and the incidence of depression: a nationwide population-based study (2010-2017).Eye (London, England) · 2025Article
- Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.Journal of ophthalmology · 2025Article
- Determinants of Healthcare Professionals' Knowledge on Age-Related Macular Degeneration Risk Factors in Ethiopia.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- EvaluatingMedicina (Kaunas, Lithuania) · 2024Article
- Understanding barriers and enablers to participation in a proposed online lifestyle intervention for older adults with age-related macular degeneration to guide programme implementation.Journal of health psychology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
purpose of reviewThis review updates the literature on depression in age-related macular degeneration (AMD). Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed. RECENT
findingsDepression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved. SUMMARY: AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.